WallStSmart
LEXX

Lexaria Bioscience Corp

NASDAQ: LEXX · HEALTHCARE · BIOTECHNOLOGY

$0.66
-4.34% today

Updated 2026-04-30

Market cap
$23.56M
P/E ratio
P/S ratio
64.01x
EPS (TTM)
$-0.47
Dividend yield
52W range
$0 – $2
Volume
0.2M

Lexaria Bioscience Corp (LEXX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$253147.00$900789.00$421955.00$362471.00$1.13M$1.36M$1.10M$1.10M$1.10M$14702.00$40718.00$63639.00$433287.00$222610.00$314793.00$722738.00$255396.00$226208.00$464278.00$705923.00
Revenue growth (YoY)+255.8%-53.2%-14.1%+212.8%+19.8%-19.2%+0.0%+0.0%-98.7%+177.0%+56.3%+580.9%-48.6%+41.4%+129.6%-64.7%-11.4%+105.2%+52.0%
Cost of revenue$274094.00$805949.00$549576.00$274636.00$668280.00$783268.00$795204.00$795204.00$795204.00$29883.00$46234.00$31238.00$27492.00$416642.00$245470.00$175346.00$208683.00$172246.00$80975.00$118572.00
Gross profit$-20946.00$94839.00$-127621.00$87835.00$465486.00$574494.00$302251.00$302251.00$302251.00$-15181.00$-5516.00$32401.00$405795.00$-194032.00$69323.00$547392.00$46714.00$53962.00$383303.00$587351.00
Gross margin-8.3%10.5%-30.2%24.2%41.1%42.3%27.5%27.5%27.5%-103.3%-13.5%50.9%93.7%-87.2%22.0%75.7%18.3%23.9%82.6%83.2%
R&D$146466.00$9024.00$54185.00$492864.00$555730.00$387074.00$1.26M$1.84M$3.67M$2.36M$8.24M
SG&A$121442.00$1.01M$475339.00$458037.00$466670.00$678090.00$561888.00$364114.00$1.27M$1.49M$1.01M$1.63M$6.02M$3.13M$3.57M$4.97M$5.72M$3.06M$3.85M$4.35M
Operating income$-1.06M$-384609.00$-488378.00$-358307.00$-259500.00$-13867.00$-56901.00$-76112.00$294057.00$-1.93M$-1.26M$-1.92M$-6.61M$-4.14M$-4.13M$-5.52M$-6.50M$-6.53M$-5.70M$-11.63M
Operating margin-418.1%-42.7%-115.7%-98.9%-22.9%-1.0%-5.2%-6.9%26.8%-13115.3%-3093.5%-3022.4%-1526.3%-1860.6%-1311.6%-763.8%-2545.4%-2888.5%-1226.7%-1648.0%
EBITDA$-891031.00$-414374.00$-244369.00$-236151.00$56073.00$442731.00$266868.00$266868.00$294057.00$-1.95M$-1.26M$-1.92M$-6.61M$-4.10M$-4.00M$-4.02M$-7.24M$-6.57M$-5.73M$-11.80M
EBITDA margin-352.0%-46.0%-57.9%-65.2%4.9%32.6%24.3%24.3%26.8%-13269.5%-3092.0%-3020.1%-1524.8%-1840.8%-1271.5%-555.7%-2833.5%-2903.1%-1234.7%-1670.9%
EBIT$-1.04M$-867492.00$-586498.00$-358308.00$-314551.00$-13867.00$-76194.00$-76194.00$294057.00$-1.93M$-1.26M$-1.92M$-6.61M$-4.16M$-4.15M$-4.16M$-7.38M$-6.71M$-5.81M$-11.91M
Interest expense$21909.00$4708.00$857581.00$160121.00$167322.00$237641.00$246606.00$267357.00$267357.00$31544.00$2250.00$6015.00$0.00$0.00$0.00$0.00$114329.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-1.06M$-978490.00$-753573.00$-552462.00$-538226.00$-251508.00$-343551.00$-343551.00$-1.87M$-1.77M$-1.21M$-1.87M$-6.60M$-4.10M$-3.93M$-4.03M$-7.27M$-6.66M$-5.80M$-11.90M
Net income growth (YoY)+7.3%+23.0%+26.7%+2.6%+53.3%-36.6%+0.0%-444.7%+5.4%+31.4%-53.9%-253.0%+37.9%+4.0%-2.4%-80.5%+8.3%+13.0%-105.4%
Profit margin-417.1%-108.6%-178.6%-152.4%-47.5%-18.5%-31.3%-31.3%-170.5%-12042.6%-2983.4%-2937.3%-1523.0%-1841.5%-1249.7%-557.2%-2846.3%-2946.4%-1248.2%-1686.0%